CD8A and neoplasm: To explore differences in tumor- and stroma-specific subtypes, we investigated their associations with DNA damage (γH2AX expression) and immunological features including cluster of differentiation 3 (CD3), cluster of differentiation 8 (CD8), and programmed death ligand 1 (PD-L1).